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A novel and practical cardiovascular magnetic
resonance method to quantify mitral annular
excursion and recoil applied to hypertrophic
cardiomyopathy
Shahryar G Saba1,3, Sohae Chung2, Sharath Bhagavatula2, Robert Donnino1,2, Monvadi B Srichai1,2,4,
Muhamed Saric1, Stuart D Katz1 and Leon Axel1,2*

Abstract
Background: We have developed a novel and practical cardiovascular magnetic resonance (CMR) technique to
evaluate left ventricular (LV) mitral annular motion by tracking the atrioventricular junction (AVJ). To test AVJ motion
analysis as a metric for LV function, we compared AVJ motion variables between patients with hypertrophic
cardiomyopathy (HCM), a group with recognized systolic and diastolic dysfunction, and healthy volunteers.
Methods: We retrospectively evaluated 24 HCM patients with normal ejection fractions (EF) and 14 healthy
volunteers. Using the 4-chamber view cine images, we tracked the longitudinal motion of the lateral and septal AVJ
at 25 time points during the cardiac cycle. Based on AVJ displacement versus time, we calculated maximum AVJ
displacement (MD) and velocity in early diastole (MVED), velocity in diastasis (VDS) and the composite index VDS/MVED.
Results: Patients with HCM showed significantly slower median lateral and septal AVJ recoil velocities during early
diastole, but faster velocities in diastasis. We observed a 16-fold difference in VDS/MVED at the lateral AVJ [median
0.141, interquartile range (IQR) 0.073, 0.166 versus 0.009 IQR −0.006, 0.037, P < 0.001]. Patients with HCM also
demonstrated significantly less mitral annular excursion at both the septal and lateral AVJ. Performed offline, AVJ
motion analysis took approximately 10 minutes per subject.
Conclusions: Atrioventricular junction motion analysis provides a practical and novel CMR method to assess mitral
annular motion. In this proof of concept study we found highly statistically significant differences in mitral annular
excursion and recoil between HCM patients and healthy volunteers.
Keywords: Cardiovascular magnetic resonance, Mitral annular motion, Left ventricular function, Hypertrophic
cardiomyopathy

Background
Atrioventricular plane displacement, a measure of longitudinal left ventricular (LV) function, accounts for approximately 60% of the stroke volume [1]. Reduced
mitral annular plane systolic excursion (MAPSE), measured by M-mode echocardiography, provides a sensitive,
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early marker of systolic dysfunction in hypertensive patients with preserved EF, and can diagnose heart failure
with preserved EF [2]. Mitral annular velocity (E’), measured in early diastole by tissue Doppler echocardiography, incrementally predicts cardiac mortality beyond
clinical data and standard echocardiographic measures
[3,4]. At the present time, however, there is still no simple, validated cardiovascular magnetic resonance (CMR)
technique to measure mitral annular excursion and
recoil.
In the current study we investigated the movement of
the atrioventricular junction (AVJ) throughout the cardiac
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cycle. We define the septal and lateral AVJ as myocardial
points at the corresponding left atrial-ventricular junctions in long axis cine images. The maximum longitudinal
displacement of the AVJ in systole corresponds to peak
mitral annular excursion. The maximum velocity of the
AVJ in early diastole reflects peak mitral annulus recoil
velocity during passive LV filling. We previously showed
that AVJ MVED represents a statistically significant CMR
correlate of tissue Doppler echocardiography E’ [5], and
we have confirmed these findings in a separate cohort of
patients from a different institution. We analyzed 27 patients who underwent both studies within 24 hours, and
again found a statistically significant (p = 0.001) correlation between CMR-derived MVED and E’ (r = 0.624) [6].
To test our hypothesis that hearts with systolic and
diastolic dysfunction, despite preserved EF, would demonstrate abnormal AVJ motion, we performed our analysis on patients with HCM. With the highest prevalence
of any genetic cardiac disorder, HCM affects approximately 1 in 500 individuals and may cause considerable
morbidity and mortality [7]. The disease is known to be
associated with diastolic [8] and regional LV systolic dysfunction [9].
Atrioventricular junction motion tracking software,
developed in our laboratory, measures the longitudinal
position of the AVJ on routinely obtained long axis cine
images as a function of time during the cardiac cycle.
Analysis of steady state free precession (SSFP) cine images provides better temporal resolution compared to
conventional phase-contrast imaging techniques [10]
used to evaluate myocardial velocity, without adding to
acquisition time. Performed offline, in an efficient manner, AVJ motion analysis quantifies mitral annular excursion and recoil.

Methods
Study population

We retrospectively identified 30 consecutive patients between the ages of 21 and 64 with known or suspected
HCM who underwent CMR as part of their routine clinical assessment at one of three affiliated hospitals (New
York University Langone Medical Center, Bellevue Hospital Center, and the Manhattan Veteran’s Affairs Hospital) between February 2006 and July 2011. Eligible
patients demonstrated LV hypertrophy (LVH) of at least
15 mm, not attributable to another etiology such as
hypertension or diabetes, in a minimum of one myocardial segment. We excluded 5 patients without significant
LVH, and one patient with concomitant evidence of left
ventricular non-compaction. Prior to inception of the
current study, healthy volunteers with no significant past
medical history had been recruited to establish baseline
AVJ motion variable values. A total of 14 healthy volunteers without hypertension, diabetes mellitus, coronary
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artery disease or other significant past medical history,
and all with normal CMR examinations, were matched
for mean age and used for comparison with the 24 HCM
patients. Institutional review board approval was granted,
and informed consent was obtained from all healthy
volunteers.
CMR protocol

As part of routine clinical protocol, HCM patients underwent CMR evaluation on 1.5 T or 3 T systems (Avanto,
Tim Trio, Verio, Siemens, Erlangen, Germany) using a
torso phased-array receiver coil. Two-dimensional SSFP
pulse sequence cine imaging with electrocardiographic
gating was performed in multiplanar short and long axis
views, for evaluation of LV wall thickness, mass, segmental wall motion and global systolic function. Contrastenhanced T1-weighted inversion-recovery late gadolinium
enhancement (LGE) imaging was acquired for evaluation
of myocardial fibrosis. Delayed imaging was performed
10 minutes after patients received intravenous gadoliniumdiethylenetriamine penta-acetic acid (0.15 mmol/kg)
contrast agent. Quantitative measurements of LV volumes, EF and mass, as well as qualitative assessments of
LA size, severity of mitral regurgitation and systolic anterior motion of the mitral valve leaflets were performed. Post-processing, including the measurement of
LV wall thickness, was performed on each segment of a
17-segment LV model, excluding the apical cap.
Healthy volunteers were imaged with a 3 T CMR system
(Tim Trio, Siemens, Erlangen, Germany), using standard
phased-array coils. Typical imaging parameters for patients and healthy volunteers included: TR = 2.4 ms,
TE = 1.4 ms, flip angle 51°, slice thickness = 6 mm, inplane spatial resolution = 1.6 mm × 1.6 mm, receiver
bandwidth = 930 Hz/pixel, 20–30 phases (average 25
phases) per cardiac cycle and temporal resolution ~ 45 ms.
To cover late diastolic filling, image acquisition was performed throughout the cardiac cycle with retrospectively
gated reconstruction.
Image and data analyses

Atrioventricular motion was measured at the septal and
lateral junction points between the left atrium and ventricle in the 4-chamber cine view. A reference line was
placed through the LV apex and the midpoint of the mitral
annulus (Figure 1). The AVJ demonstrated an arc-like motion with longitudinal (toward the apex) and radial (toward the center of the mitral annulus) components. The
longitudinal displacement was effectively measured as the
distance between a perpendicular line through the reference line and AVJ at end diastole, and a perpendicular line
through the reference line and AVJ at the given time point
in the cardiac cycle. This distance was interactively measured over the cardiac cycle, using our custom-written
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length) was determined. The slopes between sequential
points of the normalized displacement-versus-time
curve were calculated and plotted, resulting in a normalized velocity-versus-time curve. The maximum normalized velocity of the AVJ during early passive mitral filling
(MVED), and the best-fit line of normalized AVJ velocity
in diastasis (VDS) were also calculated. In order to establish intra-study reliability, AVJ motion analysis was also
performed in a previously described cohort of patients referred for CMR [5] using both 3- and 4-chamber long axis
cine images.
Statistical methods

Figure 1 Septal and lateral AVJ. Yellow and red asterisks mark the
septal and lateral AVJ, respectively, on this 4-chamber view. A reference
line for longitudinal AVJ motion bisects the LV between the apex and
the midpoint of the mitral annulus. AVJ = atrioventricular junction;
LV = left ventricle.

(MATLAB, Natick, MA) AVJ motion-tracking software.
Standardized atrioventricular junction motion analysis
was performed off-line and took approximately 10 minutes
per subject.
All distances measured were divided by the longitudinal length of the LV at end diastole to provide an approximate correction for individual heart sizes. The AVJ
was identified and marked on each of the cine phases
obtained (Figure 2), and several motion variables were
calculated (Figure 3). Based on the resulting timeversus-displacement plot, the AVJ motion variable MD
(maximum displacement normalized by end-diastolic

The continuous AVJ motion variables are presented as
medians and IQR. Comparisons between AVJ motion
variables in healthy volunteers and HCM patients were
made using the Mann–Whitney U test. Box-and-whisker
plots were generated to graphically represent differences
between the two groups. Inter-reader variability analysis
was performed on the healthy volunteer cohort data obtained by two independent observers. To assess intrastudy reproducibility, intraclass correlation coefficients
were also obtained in a separate cohort of patients that
was previously described [5]. SPSS Statistics Version 20
was used to carry out all statistical analysis.

Results
Patient characteristics and CMR parameters

The mean age of the HCM patients and healthy volunteers in the study was 45 (range 25–59) and 46 (range
31–64), respectively. The mean thickness of the maximally hypertrophied segment was found to be 23 mm
(range 16–32 mm). On average, each patient had 4.5
segments of myocardial hypertrophy (range 2–9). All
HCM patients were found to have normal or increased
EF (Table 1). Of the 24 patients analyzed, 18 (75%)

Figure 2 AVJ displacement-versus-time plot and images. Atrioventricular junction motion tracking software interactively measures the
longitudinal AVJ position at multiple time points during the cardiac cycle. Error bars represent one standard deviation above and below the
mean of multiple independent measurements made on a representative healthy volunteer. Lateral AVJ position, marked with a red asterisk,
shown at the start of systole (A), end systole (B), diastasis (C) and end diastole (D) for a representative 4-chamber cine image set.
AVJ = atrioventricular junction.
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inferolateral and inferior segments, the majority were
localized to the basal and mid anterior and septal
segments.
Late gadolinium enhancement

Of the 24 patients analyzed, 20 (83%) demonstrated regions of LGE consistent with myocardial fibrosis. None
of the lateral wall segments showed evidence of LGE.
The most common location of fibrosis was found to be
in the basal anteroseptum (14 patients, 58%), followed
by the mid anteroseptum (12 patients, 50%). The majority of hypertrophied segments demonstrated LGE. Of
the 19 patients with basal anteroseptal hypertrophy, 14
(74%) were found to have LGE.
Figure 3 AVJ normalized velocity-versus-time plot. Derived from
the AVJ normalized displacement-versus-time plot (dotted), the AVJ
normalized velocity-versus-time plot (blue) shows the calculated AVJ
motion variables MVED and VDS, as indicated. The motion tracking
program directly calculates the MD from the AVJ normalized
displacement-versus-time plot. AVJ = atrioventricular junction;
MD = maximum displacement; MVED = maximum velocity early diastole;
VDS = velocity diastasis.

patients demonstrated asymmetric septal hypertrophy,
four (17%), mixed apical and asymmetric septal hypertrophy, and two (8%), concentric LVH. The most common location of maximum hypertrophy was found to be
in the basal anteroseptum (9 patients, 38%). None of the
segments in the basal or mid lateral wall or the entire inferior wall displayed maximum hypertrophy. Similarly,
the most common location of any LVH > 15 mm was the
basal anteroseptum (19 patients, 79%). Although there
were areas of hypertrophy noted in the anterolateral,
Table 1 HCM clinical and CMR characteristics
Mean (Range or % Patients)
Age (years)

45 (25–59)

Women
*

4 (17)
2

BMI (kg/m )

26 (14–47)

Maximum hypertrophy (mm)

23 (16–32)

# Hypertrophied segments ≥ 15 mm
Presence SAM‡
§

4.5 (2–9)
13 (62)

Presence MR

13 (57)

Presence LGE||

20 (83)

¶

66 (58–81)

LVEDV# (mL)

160 (56–285)

LVEDVI** (mL/m2)

80 (43–134)

LV EF (%)

Presence LA† dilation

14 (70)

BMI = body mass index; †LA = left atrium; #LVEDV = left ventricle end diastolic
volume; **LVEDI = left ventricle end diastolic volume index; ¶LV EF = left
ventricle ejection fraction; ||LGE = late gadolinium enhancement; §MR = mitral
regurgitation; ‡SAM = systolic anterior motion.
*

AVJ motion analysis

We observed highly significant statistical differences in
all three AVJ motion variables (MD, MVED, and VDS)
and the composite index VDS/MVED, in patients with
HCM when compared to healthy volunteers (Table 2
and Figures 4 and 5). Patients with HCM demonstrated
significantly less normalized MD at the septal and the
lateral AVJ compared to healthy volunteers. Both the
septal and the lateral AVJ of patients with HCM recoiled
at significantly slower normalized maximum velocities (s−1)
in early diastole relative to healthy volunteers. Conversely,
during diastasis, AVJ motion showed significantly faster
normalized velocities in patients with HCM at both the
septal and lateral AVJ. We found a 16-fold difference in
the VDS/MVED ratio at the lateral AVJ and a 4-fold difference at the septal AVJ. Despite the far fewer number of
hypertrophied segments and no evidence of LGE in the
lateral wall, there were no statistically significant differences between the septal and lateral AVJ motion variables
within the HCM group. Similarly, when comparing septal
to the lateral AVJ motion variables within the healthy volunteers, we observed no significant differences. Twenty of
24 (83%) HCM exhibited LGE. Comparing HCM patients
with and without LGE, we found no statistically significant
differences in any of the AVJ motion variables (MD,
MVED, VDS and VDS/MVED) at either septal or lateral
AVJ. In comparison to healthy volunteers however, both
HCM patients with and the four patients (17%) without
LGE demonstrated statistically significant differences in
MVED, VDS and VDS/MVED (Table 3 and Figure 6) at
both the septal and lateral AVJ. Our results demonstrate
good reproducibility, based on normal volunteer data intraclass correlation coefficients obtained by two independent
observers of 0.84 (p < 0.001), 0.92 (p < 0.001), 0.84 (p = 0.001)
and 0.79 (p = 0.006) for MD, MVED, VDS and VDS/MVED,
respectively. Intra-study reliability analysis revealed intraclass
correlation coefficients of 0.84 (p < 0.001), 0.55 (p = 0.003),
0.78 (p < 0.001) and 0.47 (p = 0.023) for MD, MVED, VDS
and VDS/MVED, respectively.
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Table 2 Comparison of median AVJ motion variables between healthy volunteers and HCM patients for the lateral and
septal AVJ
Median
*

Lateral AVJ
||

−1

75th percentile

Median

−0.165

25th percentile

75th percentile

P

−0.083

<0.001

‡

Control
−0.149

MD§

25th percentile

HCM
−0.125

−0.107

−0.121

MVED (s )

1.082

0.854

1.343

0.506

0.395

0.634

<0.001

VDS¶ (s−1)

0.012

−0.008

0.037

0.067

0.047

0.078

<0.001

VDS/MVED

0.009

−0.006

0.037

0.141

0.073

0.166

<0.001

Septal AVJ

Control

HCM

MD

−0.149

−0.173

−0.130

−0.116

−0.130

−0.100

<0.001

MVED (s−1)

0.947

0.628

1.033

0.537

0.406

0.635

0.001

VDS (s )

0.027

0.004

0.060

0.074

0.040

0.109

0.006

VDS/MVED

0.029

0.004

0.056

0.126

0.090

0.249

<0.001

−1

AVJ = atrioventricular junction; ‡HCM = hypertrophic cardiomyopathy; §MD = maximum displacement; ||MVED = maximum velocity early diastole;
VDS = velocity diastasis.

*

¶

Discussion
AVJ motion tracking

We have demonstrated the feasibility of a novel and
practical CMR technique, developed in our laboratory,
to track longitudinal AVJ motion throughout the cardiac
cycle. Using this technique, several AVJ motion variables
relating to LV function can be measured. While novel to
CMR, these variables are derived from principles relevant

to assessment of systolic and diastolic function by established echocardiographic measurements.
The MD, measured from the displacement-versus-time
curve at end systole, reflects longitudinal mitral annular
excursion and corresponds to echocardiographic MAPSE.
Since mitral annular excursion occurs with longitudinal
LV contraction and MAPSE predicts EF [11], the MD variable provides a measure of regional, longitudinal, as well

B
A

Figure 4 HCM and healthy volunteer AVJ displacement-versus-time and velocity-versus-time plots. A. Longitudinal AVJ displacement
plotted as a function of time during the cardiac cycle in a representative HCM patient (red) and healthy volunteer (black). The healthy volunteer
demonstrates a significantly greater MD compared to the patient with HCM. B. Derived from the displacement-versus-time curves, the velocity-versus-time
plots show a significantly decreased recoil velocity during early diastole (MVED) in the HCM patient compared to the healthy volunteer. AVJ = atrioventricular
junction; HCM = hypertrophic cardiomyopathy; MD = maximum displacement; MVED = maximum velocity early diastole.
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Figure 5 Box plots of AVJ motion variables in HCM patients and healthy volunteers. The box plots display the sample minimum (lower
whisker), lower quartile (lower box subdivision), median (horizontal band), upper quartile (upper box subdivision), and sample maximum (upper
whisker) for each of the AVJ motion variables MD, MVED, VDS and VDS/MVED at the lateral and septal AVJs in healthy volunteers and HCM
patients. Circles indicate outliers. P ≤ 0.006 for all. AVJ = atrioventricular junction; HCM = hypertrophic cardiomyopathy; MD = maximum
displacement; MVED = maximum velocity early diastole; VDS = velocity diastasis.

Table 3 Comparison of median AVJ motion variables
between healthy volunteers and HCM patients with and
without LGE
Lateral

P

P

AVJ*

HCM‡ LGE§+
vs
Healthy Volunteers

HCM LGEvs
Healthy Volunteers

MD||

<0.001

NS

MVED¶ (s−1)

<0.001

0.001

VDS# (s−1)

<0.001

0.003

VDS/MVED

<0.001

0.001

Septal

P

P

AVJ

HCM LGE+
vs
Healthy Volunteers

HCM LGEvs
Healthy Volunteers

MD

<0.001

NS

MVED (s−1)

0.001

0.032

VDS (s−1)

0.005

0.045

VDS/MVED

<0.001

0.023

AVJ = atrioventricular junction; ‡HCM = hypertrophic cardiomyopathy; §LGE = late
gadolinium enhancement; ||MD = maximum displacement; ¶MVED = maximum
velocity early diastole; #VDS = velocity diastasis.
*

as global LV function. To account for variability in LV size,
we normalized the MD variable by the longitudinal LV
length. Since the heart apex remains approximately stationary throughout the cardiac cycle, the normalized MD
corresponds approximately to the maximum systolic strain
derived by tissue Doppler echocardiography. The general
shape of the observed AVJ displacement-versus-time curve
resembles the expected strain-versus-time and LV volumeversus-time curves.
We also measured MVED, the maximum normalized
velocity of the AVJ during the early, passive phase of diastole. This variable is measured from the AVJ normalized velocity-versus-time curve, which is derived by
measuring the slope between sequential time points on
the normalized displacement-versus-time curve. As we
previously showed, MVED represents a statistically significant CMR correlate of mitral annulus E’ measured by
tissue Doppler echocardiography [5]. Since we normalized the displacement measurements to the end-diastolic
longitudinal LV length, MVED also approximately corresponds to maximum early diastolic strain rate measured
by tissue Doppler. Consequently, the general shape of the
AVJ velocity-versus-time curve resembles the expected
strain rate-versus-time curve. In contrast to strain and
strain rate measured by tissue Doppler, which detects
differences in velocity between two adjacent areas of
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Figure 6 Box plots of AVJ motion variables in HCM patients with and without LGE compared to healthy volunteers. The box plots
display the sample minimum (lower whisker), lower quartile (lower box subdivision), median (horizontal band), upper quartile (upper box
subdivision), and sample maximum (upper whisker) for each of the AVJ motion variables MD, MVED, VDS and VDS/MVED at the lateral and septal
AVJ in healthy volunteers and HCM patients with and without LGE. Circles indicate outliers. Both HCM patients with and without LGE
demonstrated statistically significant differences (P < 0.05) in MVED, VDS and VDS/MVED at both the lateral and septal AVJ compared to
healthy volunteers. AVJ = atrioventricular junction; HCM = hypertrophic cardiomyopathy; LGE = late gadolinium enhancement; MD =
maximum displacement; MVED = maximum velocity early diastole; VDS = velocity diastasis.

myocardium, AVJ motion variables reflect changes in
position of a single material point. The AVJ can be accurately tracked throughout the cardiac cycle, given the
excellent spatial resolution of CMR and the clear signal
intensity difference between myocardium and fat in the
adjacent atrioventricular groove.
We also measured the normalized velocity of the AVJ
in diastasis, VDS, by finding the best-fit line through the
normalized velocity-versus-time curve during the quiescent phase of diastole. The composite index VDS/MVED
was calculated to accentuate the individual differences in
the AVJ motion variables we noted when comparing patients with HCM to healthy volunteers.
AVJ motion variable comparison

While all HCM patients in our study demonstrated normal or increased EF, they showed decreased MD for
both the septal and lateral AVJ. As the MD corresponds
to longitudinal mitral annular excursion of a single point
at the AVJ, this may reflect altered regional rather than
global systolic function. Similar discrepancies between
global and regional systolic function had previously been
observed used tagged-CMR sequences in patients with
HCM [9]. In a pediatric population with HCM, Ganame
et al. [12] demonstrated regional differences in strain, although global measures of systolic function were preserved. Reductions in longitudinal shortening in HCM

may be compensated for by an increase in LV torsion
[13], resulting in preserved global systolic function. When
comparing the septal versus lateral AVJ MD within the
HCM group, we found no significant differences despite
the relative sparing of hypertrophy and fibrosis in the
lateral wall. Our findings therefore suggest that regional
systolic dysfunction may be present in patients with
HCM, independent of hypertrophy, fibrosis and global
LV function.
As expected, we noted slower velocities of the septal
AVJ in HCM patients compared to healthy controls.
Somewhat unexpectedly, however, we also found slower
velocities of the lateral AVJ, despite the relative sparing
of hypertrophy and fibrosis in this region. When comparing the septal and lateral AVJ velocities within the
HCM group, we again found no significant differences.
These findings agree with the significantly lower septal
and lateral E’ velocities noted by Severino et al. [14]
when comparing individuals with HCM to healthy controls. Another echocardiographic study demonstrated that
individuals with certain genotype (+) HCM, but without
morphologic evidence of LVH, exhibit significantly lower
systolic and early diastolic mitral annulus tissue Doppler
velocities compared to healthy controls [8]. These data
support a hypertrophy-independent mechanism for regional systolic and diastolic dysfunction in patients with
HCM. The diffuse increase in collagen content of HCM
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hearts [15], even in the absence of focal fibrosis identified
by LGE, may contribute to myocardial dysfunction, as
we observed in the lateral wall segments of our patient
cohort. However, the four HCM patients without LGE
also demonstrated statistically significant differences in
MVED, VDS and VDS/MVED, at both the septal and
lateral AVJ, compared to healthy volunteers. These results further suggest that myocardial dysfunction may
occur in the absence of fibrosis detected by LGE. The
small sample size of HCM patients without LGE likely
precluded the demonstration of statistically significant
differences in MD. In contrast to HCM disease models
implicating abnormal myocyte contractility as the primary disturbance, an alternative ‘energy compromise’
hypothesis has been proposed. Crilley et al. [16] demonstrated that abnormalities in myocyte energy metabolism
can occur in three different HCM genes, independent of
LVH, and therefore may affect energy-dependent processes, such as the active relaxation phase of diastole. Impaired cardiomyocyte calcium handling, resulting from
alterations in a variety of signal transduction pathways,
can affect diastolic function as well [17].
We noted significantly higher normalized velocities of
both septal and lateral AVJ during diastasis in HCM patients, indicating the extension of relaxation and passive
filling into the normally quiescent phase of diastole. Elevations in left atrial pressure may account in part for the
persistence of blood flow across the mitral annulus during diastasis, and the correspondingly higher AVJ velocities in this phase of diastole. The higher velocities could
also represent a prolongation of the initial, normally
rapid relaxation phase of early diastole into the normally
quiescent period of mid-diastole. The increased middiastolic velocities may be analogous to the L wave
noted on mitral inflow in certain patients with elevated
filling pressures. Interestingly, a small subset of patients
noted to have triphasic mitral inflow by Ha et al. [18]
carried the diagnosis of HCM.
Limitations

Our retrospective proof-of-concept study has several limitations, including a small sample size of HCM patients,
which included only 4 women (17%). The cardiac MR studies performed on healthy volunteers did not include short
axis cine images, so LV EF, although qualitatively normal,
was not quantified. Although we previously demonstrated a
statistically significant correlation between MVED and tissue Doppler echocardiography E’, AVJ motion and echocardiography variables were not directly correlated in this
HCM cohort. However, the known E’ velocity reduction in
patients with HCM, in conjunction with the decreased
MVED we found associated with HCM and the two previous studies correlating E’ and MVED, indicate the relevance of AVJ motion tracking findings in HCM.
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Conclusions
Atrioventricular junction motion tracking, a practical technique developed in our laboratory, assesses mitral annular
excursion and recoil by CMR. Using this novel approach,
we observed highly statistically significant differences in
AVJ motion variables in HCM patients compared to
healthy volunteers. Even with relative sparing of hypertrophy and LGE, the morphologically normal-appearing
HCM lateral wall also showed abnormal AVJ motion.
Atrioventricular junction motion analysis can be performed efficiently on cine sequences that are obtained
in nearly all CMR evaluations, without the need for additional acquisition time.
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